Protease-Activated Receptor 2 Inhibition Sensitized Non-Small Cell Lung Cancer Cells to Gefitinib Upon Epidermal Growth Factor Receptor Transactivation. The gene discussed is F2RL1; the disease is non-small cell lung carcinoma.